Zhukovsky, S., White, J., Chakraborty, R., Costa, L. J., Van Oekelen, O., Sborov, D. W., Cliff, E. R. S., & Mohyuddin, G. R. (2024). Multiple myeloma clinical trials exclude patients with the highest-risk disease: a systematic review of trial exclusion criteria. Leukemia & Lymphoma, 1–10. https://doi.org/10.1080/10428194.2024.2395440

Sudunagunta, V. S., & Viny, A. D. (2024). Untangling the loops of STAG2 mutations in myelodysplastic syndrome. Leukemia & Lymphoma, 1–10. https://doi.org/10.1080/10428194.2024.2400210

Adeuyan, O., Ouseph, M. M., Bao, L., Kluk, M. J., Goldberg, J. S., Geskin, L. J., & Magro, C. M. (2024). A case of testicular diffuse large B-cell lymphoma with late relapse in the skin: the critical role of comparative phenotypic, clonality, and cytogenetic testing. Leukemia & Lymphoma, 1–5. https://doi.org/10.1080/10428194.2024.2374455

Gordon, E. R., Trager, M. H., Kwinta, B. D., Stonesifer, C. J., Lee, K. J., Adeuyan, O., Lapolla, B. A., Akilov, O. E., Enz, P. A., Guenova, E., Ortiz-Romero, P. L., Papadavid, E., Quaglino, P., Rozati, S., Scarisbrick, J. J., Litman, T., & Geskin, L. J. (2024). Maintenance therapy for CTCL: importance for prevention of disease progression. Leukemia & Lymphoma, 1–8. https://doi.org/10.1080/10428194.2024.2376164

Gordon, E. R., Chen, C., Trager, M. H., Adeuyan, O., Lapolla, B. A., Fahmy, L. M., Schreidah, C. M., Wetter, D. A., & Geskin, L. J. (2024). Gammopathic dermopathy: characterization of cutaneous MGUS. Leukemia & Lymphoma, 65(7), 989–996. https://doi.org/10.1080/10428194.2024.2336046

Ryu Tiger, Y. K., Jain, S., Barta, S. K., Tolu, S., Estrella, B., Sawas, A., Lue, J. K., Francescone, M. M., Pro, B., & Amengual, J. E. (2024). Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leukemia & Lymphoma, 65(6), 736–745. https://doi.org/10.1080/10428194.2024.2329996

Gordon, E. R., Kwinta, B. D., Schreidah, C. M., Fahmy, L. M., Adeuyan, O., Queen, D., Trager, M. H., Magro, C. M., & Geskin, L. J. (2023). Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes. Leukemia & Lymphoma, 65(1), 48–54. https://doi.org/10.1080/10428194.2023.2270766

Mellgard, G., Stoffel, E., Michel, A., Iqbal, F., Provenzano, A., Akpan, I. J., Amengual, J., & Pro, B. (2023). Hypereosinophilic syndrome with leptomeningeal involvement: a not-so-classical case report of classical Hodgkin Lymphoma. Leukemia & Lymphoma, 64(13), 2208–2213. https://doi.org/10.1080/10428194.2023.2252124

Prebet, T., Goldberg, A. D., Jurcic, J. G., Khaled, S., Dail, M., Feng, Y., Green, C., Li, C., Ma, C., Medeiros, B. C., Yan, M., & Grunwald, M. R. (2022). A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia. Leukemia & Lymphoma, 63(9), 2180–2188. https://doi.org/10.1080/10428194.2022.2057484

Hopson, M. B., Bhutani, D., Sarkaria, S., Maurer, M. S., Griffin, J. M., Mapara, M., Lentzsch, S., & Chakraborty, R. (2022). Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis. Leukemia & Lymphoma, 63(9), 2109–2113. https://doi.org/10.1080/10428194.2022.2060502